SN Bioscience’s Nano Anti-Cancer Drug, “SNB-101”, Earns Orphan Drug Designation from US FDA for Small Cell Lung Cancer with Exclusive Rights for 7 Years
Pharmaceutical research and development company SN Bioscience (CEO Park Young-hwan) has secured orphan drug designation from the US Food and ...
